QIAFLEX-DX
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

QIAFLEX-DX Trademark

Serial Number: 97541217

QIAFLEX-DX is a trademark filed by QIAGEN NORTH AMERICAN HOLDINGS, INC. on August 9, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

QIAGEN NORTH AMERICAN HOLDINGS, INC. (30 trademarks)

19300 GERMANTOWN ROAD
GERMANTOWN, MD 20874

Entity Type: 03

NeuMoDx Molecular, Inc. (5 trademarks)

Ann Arbor, MI 48108

Entity Type: 03

Trademark Details

Filing Date

August 9, 2022

Registration Date

Not Registered

Published for Opposition

July 25, 2023

Goods & Services

Apparatus for testing gas, liquids and solids; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Spectrograph apparatus

Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic reagents and contrast media for medical use; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes

Assays and reagents for use in genetic research; Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagents for use in scientific apparatus for chemical or biological analysis

Apparatus for blood analysis; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Displays, monitors and controllers for medical fluid injectors, namely, computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses; Instruments and apparatus for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management downloadable and recorded software sold as a unit

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 21, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2024 ABN6
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 10, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 12, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 12, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2023 CNRT
ASSIGNED TO EXAMINER
May 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2022 NWOS
NEW APPLICATION ENTERED
Aug 12, 2022 NWAP